Skip to Main Content

Author Details

Dirk De Ruysscher
Maastro Clinic
1983
466
75
PMIDPaper TitleJournal TitlePublished Year
37652302A Framework for Assessing the Effect of Cardiac and Respiratory Motion for Stereotactic Arrhythmia Radioablation Using a Digital Phantom With a 17-Segment Model: A STOPSTORM.eu Consortium Study.Int J Radiat Oncol Biol Phys2024
37908014Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer".Int J Cancer2024
36375562Cost-effectiveness of proton radiotherapy versus photon radiotherapy for non-small cell lung cancer patients: Exploring the model-based approach.Radiother Oncol2023
37862240Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types.JNCI Cancer Spectr2023
37806559Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E<sup>2</sup>-RADIatE platform.Radiother Oncol2023
37713940Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy.Breast2023
37524025Trends in the epidemiology of small-cell lung cancer: a Dutch nationwide population-based study over 1989-2020.Eur J Cancer2023
37745558Decoding biological age from face photographs using deep learning.medRxiv2023
37548182Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomes.Acta Oncol2023
37827279Refining critical structure contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark results and consensus guidelines from the STOPSTORM.eu consortium.Radiother Oncol2023
37576068Clinical implementation of standardized neurocognitive assessment before and after radiation to the brain.Clin Transl Radiat Oncol2023
35640975Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small cell lung cancer reduces hippocampal atrophy compared to conventional PCI.Neuro Oncol2023
37419045Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitors.Lung Cancer2023
37451182Treatment outcome of patients with synchronous oligometastatic non-small cell lung cancer in the immunotherapy era: Analysis of a real-life intention-to-treat population.Eur J Cancer2023
37284695Trial watch: chemotherapy-induced immunogenic cell death in oncology.Oncoimmunology2023
37284297Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675).JTO Clin Res Rep2023
37210766Stereotactic body radiation therapy in unresectable stage III non-small cell lung cancer: A systematic review.Cancer Treat Rev2023
37437607Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.Radiother Oncol2023
37403702(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer.Int J Cancer2023
37296973The Association of Gross Tumor Volume and Its Radiomics Features with Brain Metastases Development in Patients with Radically Treated Stage III Non-Small Cell Lung Cancer.Cancers (Basel)2023
37164108In Response to Arcidiacono et al.: "Should dose intensification be discontinued or should accelerated schemes remain an important area of clinical research?"Radiother Oncol2023
37397874Clinical evaluation of synthetic computed tomography methods in adaptive proton therapy of lung cancer patients.Phys Imaging Radiat Oncol2023
37294262Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.Pract Radiat Oncol2023
36857819Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors.Eur J Cancer2023
36880063Machine learning for normal tissue complication probability prediction: Predictive power with versatility and easy implementation.Clin Transl Radiat Oncol2023
36584393Roadmap for precision preclinical x-ray radiation studies.Phys Med Biol2023
36442608Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.Radiother Oncol2023
36396145European Respiratory Society guideline on various aspects of quality in lung cancer care.Eur Respir J2023
36842666Computed tomography and radiation dose images-based deep-learning model for predicting radiation pneumonitis in lung cancer patients after radiation therapy.Radiother Oncol2023
36934893Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study.Radiother Oncol2023
36931075Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations.Eur J Cancer2023
34562610Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.Ann Oncol2022
35840111No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.Int J Radiat Oncol Biol Phys2022
35647396Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort.Adv Radiat Oncol2022
35535474Clinician perspectives on clinical decision support systems in lung cancer: Implications for shared decision-making.Health Expect2022
35496817A scoping review of small animal image-guided radiotherapy research: Advances, impact and future opportunities in translational radiobiology.Clin Transl Radiat Oncol2022
35756675Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.Front Oncol2022
35393508Imaging immunity in patients with cancer using positron emission tomography.NPJ Precis Oncol2022
35691097Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey.Lung Cancer2022
35777706Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches.Ann Oncol2022
36497476Association of Pretreatment Physical and Geriatric Parameters with Treatment Tolerance and Survival in Elderly Patients with Stage I-II Non-Small Cell Lung Cancer: An Evaluation of Usual Care Data.Cancers (Basel)2022
36248338International consensus on radiotherapy in metastatic non-small cell lung cancer.Transl Lung Cancer Res2022
36174633European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making.Lancet Oncol2022
36067908A traffic light protocol workflow for image-guided adaptive radiotherapy in lung cancer patients.Radiother Oncol2022
36130474Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort.EBioMedicine2022
36032350Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.Ther Adv Med Oncol2022
36195214The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.Radiother Oncol2022
35014216Physical exercise at the crossroad between muscle wasting and the immune system: implications for lung cancer cachexia.J Cachexia Sarcopenia Muscle2022
34915064Implementation of MR-linac and proton therapy in two radiotherapy departments in The Netherlands: Recommendations based on lessons learned.Radiother Oncol2022
35093408The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation.Radiother Oncol2022
  • 1 - 50 of 466

Recommended Authors

Soumyajit Roy
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 2
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 7
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 7
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 3
Nikhil T Sebastian
Emory University
Career Start Year 2011
Number of shared co-authors 1
Joseph Sia
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2011
Number of shared co-authors 5
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 5
Hanbo Chen
University of Toronto
Career Start Year 2010
Number of shared co-authors 9
Saiama N Waqar
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 6
Stephen Barnett
Royal Melbourne Hospital
Career Start Year 2006
Number of shared co-authors 5
Paul Wheatley-Price
The Ottawa Hospital Research Institute
Career Start Year 2005
Number of shared co-authors 4
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 13
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 9
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 5
Daniel Morgensztern
Washington University School of Medicine
Career Start Year 2000
Number of shared co-authors 3
Michael Bergqvist
Umea University
Career Start Year 1998
Number of shared co-authors 0
Young Mog Shim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Cheryl Ho
University of British Columbia
Career Start Year 1995
Number of shared co-authors 3
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 2
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 3
Charles R Thomas
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 7
William F Hartsell
Proton Therapy Center- Northwestern University
Career Start Year 1989
Number of shared co-authors 1
Philippe Maingon
Pitie-Salpetriere Hospital, AP-HP.Sorbonne Universite
Career Start Year 1988
Number of shared co-authors 12
Tsutomu Saito
Nihon University School of Medicine
Career Start Year 1987
Number of shared co-authors 0
Danielle Van den Weyngaert
University of Antwerp
Career Start Year 1987
Number of shared co-authors 4
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 5
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 6
Ramaswamy Govindan
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 1981
Number of shared co-authors 10
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Career Start Year 1977
Number of shared co-authors 10
David H Harpole
Duke University Medical Center
Career Start Year 1962
Number of shared co-authors 8

Collaborators

Philippe Lambin
Maastricht University
Co-authored papers 135
Andre Dekker
Maastricht University Medical Centre
Co-authored papers 49
Wouter van Elmpt
Maastricht University Medical Center+
Co-authored papers 48
Cary Oberije
Maastricht University Medical Centre
Co-authored papers 34
Esther G C Troost
German Cancer Research Center (DKFZ)
Co-authored papers 29
Stephanie Peeters
University of Liege, Centre Hospitalier Universitaire de Liege
Co-authored papers 29
Catharine M L West
University of Manchester
Co-authored papers 22
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 20
Barry S Rosenstein
Co-authored papers 19
Hugo J W L Aerts
Harvard Medical School
Co-authored papers 19
Ludwig Dubois
Maastricht University
Co-authored papers 13
Alison M Dunning
Co-authored papers 12
Erik Roelofs
Maastricht University Medical Centre+
Co-authored papers 11
Johan Bussink
Radboud University, Nijmegen Medical Centre
Co-authored papers 8
Marc Vooijs
Maastricht University Medical Centre+
Co-authored papers 7
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers 7
Frank J P Hoebers
Maastricht University Medical Centre
Co-authored papers 7
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Co-authored papers 7
Fiona Blackhall
The University of Manchester
Co-authored papers 6
Joost J C Verhoeff
University Medical Center Utrecht
Co-authored papers 5
Georgi Nalbantov
Department of Radiation Oncology (MAASTRO Clinic)
Co-authored papers 4
Minesh P Mehta
Co-authored papers 4
Dean A Fennell
University of Leicester
Co-authored papers 4
Emmanuel Rios Velazquez
Research Institute GROW, Maastricht University
Co-authored papers 4
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Co-authored papers 4
David A Palma
University of Western Ontario
Co-authored papers 3
Richard G Stock
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Ruud G P M van Stiphout
University of Oxford
Co-authored papers 3
Maud H W Starmans
Ontario Institute for Cancer Research
Co-authored papers 3
Ronald Boellaard
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Co-authored papers 3
Release 1.2